XML 28 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity
 3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
Stockholders' Equity

10. Stockholders’ Equity

 

In July 2019, the Company issued and sold in a private placement (i) 707,168 shares of its common stock at a price per share of $69.75 and (ii) 153,046 pre-funded warrants to purchase shares of its common stock at a price per warrant of $69.60. Each pre-funded warrant was exercisable for one share of common stock at an exercise price of $0.15 and the pre-funded warrants had no expiration date. In October 2020, 9,158 of these pre-funded warrants were exercised. As of December 31, 2022, there were no pre-funded warrants outstanding.

In March 2021, the Company issued and sold in a public offering 1,666,666 shares of its common stock at a price to the public of $83.63 per share. The Company received net proceeds of $134,878 after deducting underwriting discounts and commissions and offering expenses.

On December 2, 2022, the Company issued and sold 10,638,290 shares of its common stock at a price per share of $7.05 in a private placement, which closed immediately following the Acquisition. The Company received net proceeds of $72,551 after deducting offering costs.